Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA)

CAPS Rating: 4 out of 5

A global pharmaceutical company, Teva develops, produces, and markets generic drugs covering all major treatment categories.

Recs

0
Player Avatar MMcCabeNMC (< 20) Submitted: 2/22/2013 10:21:52 AM : Outperform Start Price: $37.89 TEVA Score: -11.45

Teva is a huge generic drug maker, with some outreach into the primary drug market. The company's balance sheet is strong, and the stock pays a reasonable dividend. With governments emphasizing cost controls for medical expense, Teva has a guaranteed market.

Featured Broker Partners


Advertisement